The distribution of histological subtypes, tumor staging, hormone receptor status, allocation to clinical subtypes of breast cancer and to treatment strategies was highly comparable to breast cancer cohorts previously described by other investigators [5]. This evidence concerns the gene NR4A1 and breast cancer.